Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Provention Bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 125 | 115 | −10 |
| Shares | 23.4M | 22.3M | −1.06M (−4.5%) |
| Value | $196.9M | $142.9M | −$54.0M (−27.4%) |
New holders (15)
Institutions that held Provention Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DG Capital Management, LLC | 544,222 | $3.48M | 0.71% |
| Connor, Clark & Lunn Investment Management Ltd. | 48,483 | $310.0K | 0.00% |
| LPL Financial LLC | 33,752 | $216.0K | 0.00% |
| Vontobel Holding Ltd. | 30,000 | $192.0K | 0.00% |
| Jump Financial, LLC | 22,600 | $145.0K | 0.01% |
| Forefront Analytics, LLC | 21,102 | $135.0K | 0.05% |
| NinePointTwo Capital | 21,077 | $134.0K | 0.05% |
| Franklin Resources Inc | 15,401 | $98.0K | 0.00% |
| Trexquant Investment LP | 14,633 | $94.0K | 0.01% |
| Parallel Advisors, LLC | 309 | $2.00K | 0.00% |
| Aspire Private Capital, LLC | 300 | $2.00K | 0.00% |
| Signaturefd, LLC | 143 | $1.00K | 0.00% |
| Column Capital Advisors, LLC | 152 | $1.00K | 0.00% |
| IFP Advisors, Inc | 42 | – | – |
| Gerber Kawasaki Wealth & Investment Management | 3 | – | – |
Sold out (25)
Institutions that held Provention Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.